Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study
Compliance with package leaflet administration instructions was significantly higher in patients with T2D receiving weekly injectable dulaglutide compared to those receiving daily oral semaglutide. This type of real-world compliance data can inform strategies to improve patient education and adherence, and physician prescribing practices, with the goal of ultimately leading to better clinical outcomes and quality of life.
Authors
- Nuria Valdés (ORCID: https://orcid.org/0000-0001-5859-257X)
- Miriam Rubio‐de Santos (ORCID: https://orcid.org/0000-0001-7393-6334)
- Esther Artime (ORCID: https://orcid.org/0000-0003-4294-6462)
- Claudia Arnas-Leon
- Gabriel Olveira (ORCID: https://orcid.org/0000-0002-7646-2899)
- Natalia Duque (ORCID: https://orcid.org/0000-0002-9587-0679)
- Jennifer Redondo‐Antón (ORCID: https://orcid.org/0000-0003-2661-5866)
- Erik Spaepen (ORCID: https://orcid.org/0000-0001-7590-7844)
- Silvia Díaz‐Cerezo (ORCID: https://orcid.org/0000-0001-6351-818X)
- Lluís Masmiquel
- Irene Rodrı́guez (ORCID: https://orcid.org/0000-0002-6605-7128)
- Agustín Ángel Merchante Alfaro (ORCID: https://orcid.org/0000-0003-1064-5331)
- Miguel Ángel Mangas Cruz (ORCID: https://orcid.org/0000-0001-5788-2778)
- María Teresa Julián Alagarda
Institutions
- University of the Basque Country (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Son Llatzer (ES)
- BioCruces Health research Institute (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- Hospital Regional Universitario de Málaga (ES)
- Hospital General Universitari de Castelló (ES)
- Eli Lilly (Spain) (ES)
- Hospital de Cruces (ES)
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/ppa.s509483
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company